X-linked inhibitor regulating TRAIL-induced apoptosis in chemoresistant human primary glioblastoma cells

Clinical and Investigative Medicine

Volumn 26, Issue 5, 2003, Pages 231-242

  Roa, Wilson H ^a,c   Chen, Hua ^a   Fulton, Dorcas ^a   Gulavita, Sunil ^b   Shaw, Andrew ^a   Th'ng, John ^b   Farr Jones, Maxine ^a   Moore, Ronald ^a   Petruk, Kenneth ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NW Ontario Regional Cancer Centre ^*  (Canada)

^c CROSS CANCER INSTITUTE   (Canada)

Author keywords

Apoptosis; Blotting, Western; Caspases; Cisplatin; Cytochrome c; Glioblastoma; Mitochondria; Mitochondrial proteins; Tumour cells, cultured

Indexed keywords

CISPLATIN; ENZYME ACTIVATOR; ETOPOSIDE; INHIBITOR OF APOPTOSIS PROTEIN; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CYTOTOXICITY; DOWN REGULATION; FLUORESCENCE MICROSCOPY; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN TRANSPORT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STAINING; TUMOR CELL; TUMOR CELL LINE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, WESTERN; CARRIER PROTEINS; CASPASE 3; CASPASE 9; CASPASES; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; CYTOCHROMES C; CYTOSOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENZYME ACTIVATION; ETOPOSIDE; GLIOBLASTOMA; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICROSCOPY, CONFOCAL; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; PROTEINS; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 0344441722     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Walker MD, Green SB, Byar DP, Alexander E Jr, Batzdorf U, Brooks WH, et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 1980;303:1323-9.
2. Fisher BJ, Scott C, MacDonald DR, Coughlin C, Curran WJ. Phase I study of topotecan plus cranial radiation for glioblastoma multiforme: results of Radiation Therapy Oncology Group Trial 9507. J Clin Oncol 2001;19:1111-7.
3. Kleinberg L, Grossman SA, Piantadosi S, Zeltman M, Wharam M. The effects of sequential versus concurrent chemotherapy and radiotherapy on survival and toxicity in patients with newly diagnosed high-grade astrocytoma. Int J Radiat Oncol Biol Phys 1999;44:535-43.
4. Roth W, Isenmann S, Naumann U, Kugler S, Bahr M, Dichgans J, et al. Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity. Biochem Biophys Res Commun 1999;265:79-83.
5. Griffith TS, Chin WA, Jackson GC, Lynch DH, Kubin MZ. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J Immunol 1998;161: 2833-40.
6. Walczak H, Krammer PH. The CD95 (Apo-1/Fas) and the TRAIL (Apo-2L) apoptosis systems. Exp Cell Res 2000;256:58-66.
7. Li H, Zhu H, Xu C-J, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondria damage in the Fas pathway of apoptosis. Cell 1998;94:491-501.
8. Li P, Nijhawan D, Budihardio I, Srinivasula SM, Ahmad M, Alnemri ES, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91:479-89.
9. Zou H, Henzel, WJ, Liu X, Lutschg A, Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997;90:405-13.
10. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev 2001;15:2922-33.
11. Salvesen GS, Duckett CS. IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 2002;3: 401-10.
12. Sasaki H, Sheng Y, Kotsuji F, Tsang BK. Downregulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. Cancer Res 2000;60:5659-66.
13. Wagenknecht B, Glaser T, Naumann U, Kugler S, Isenmann S, Bahr M, et al. Expression and biological activity of X-linked inhibitor of apoptosis (XIAP) in human malignant glioma. Cell Death Differ 1999;6: 370-6.
14. Zhang XD, Zhang XY, Gray CP, Nguyen T, Hersey P. Tumor necrosis factor-related apoptosis-inducing ligand induced apoptosis of human melanoma is regulated by Smac/DIABLO release from mitochondria. Cancer Res 2001;61:7339-48.
15. Asselin E, Mills GB, Tsang BK. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-inducing apoptosis in human ovarian epithelial cancer cells. Cancer Res 2001;61:1862-8.
16. Holcik M, Yeh C, Korneluk RG, Chow T. Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increase resistance to radiation induced cell death. Oncogene 2000;19:4174-7.
17. Holcik M, Gibson H, Korneluk RG. XIAP: apoptotic brake and promising therapeutic target. Apoptosis 2001;6:253-61.
18. Datta R, Oki E, Endo K, Biedermann V, Jian R, Kufe D. XIAP regulates DNA damage-induced apoptosis downstream of caspase-9 cleavage. J Biol Chem 2000; 275:31733-8.
19. Mansouri A, Zhang Q, Ridgway LD, Tian L, Claret FX. Cisplatin resistance in an ovarian carcinoma is associated with a defect in programmed cell death control through XIAP regulation. Oncol Res 2003;13(6-10):399-404.
20. Farr-Jones MA, Parney IF, Petruk KC. Improved technique for establishing short term human brain tumor cultures. J Neurooncol 1999;43:1-10.
21. Adam SA, Marr RS, Gerace L. Nuclear protein import in permeabilized cells requires soluble cytoplasmic factors. J Cell Biol 1990;111:807-16.
22. Madesh M, Antonsson B, Srinivasula SM, Alnemri ES, Hajnoczky G. Rapid kinetics of tBid-induced cytochrome c and Smac/DIABLO release and mitochondrial depolarization. J Biol Chem 2002;277:5651-9.
23. Ashkenazi A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer 2002;2:420-30.
24. Griffith TS, Lynch DH. TRAIL: a molecule with multiple receptors and control mechanisms. Curr Opin Immunol 1998;10:559-63.
25. Zhang XD, Nguyen T, Thomas WD, Sanders JE, Hersey P. Mechanism of resistance of normal cells to TRAIL induced apoptosis vary between different cell types. FEBS Lett 2000;482:193-9.
26. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 1999;104:155-62.
27. Fulda S, Wick W, Weller M, Debatin KM. Smac agonist sensitize for Apo2L/TRAIL or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nat Med 2002;8:808-15.
28. Hao C, Beguinot F, Condorelli G, Trencia A, Van Meir EG, Yong VW, et al. Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apoptosis in human malignant glioma cells. Cancer Res 2001;61:1162-70.
29. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli JK, et al. Two CD95 (Apo-1/Fas) signaling pathways. EMBO J 1998;17:1675-87.